OBI (OBI) News
Track canonical SquawkNews coverage tagged to OBI, OBI. This hub brings together deduplicated headlines about nasdaqgs, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Ondine Biomedical RNS flags notification of major holdings
Ondine Biomedical has issued an RNS on a standard form notification of major holdings, covering Pentwater.
EQUITY | Sep 03, 2026, 08:59 AM UTC
M
Ondine Biomedical says Lantern trial meets primary efficacy endpoint
Ondine Biomedical says its Lantern trial met the primary efficacy endpoint.
EQUITY | Sep 01, 2026, 07:21 AM UTC
M
Ondine Biomedical positive topline results in US Phase 3 study
Ondine Biomedical reported positive topline results from a US Phase 3 study.
EQUITY | Sep 01, 2026, 06:01 AM UTC